John E Gallina
CIK 1433032 · EVP & Chief Financial Officer · last filed 2026-07-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$24.84M
Companies
6
Total Filings
37
Lifetime Open-Market Net
-$36.30M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARAI | Director | 18,202 | $0.25 | $4.6K | $0 | 6 | 2026-07-07 |
| CVS | Director | 582 | $109.34 | $63.6K | $0 | 2 | 2026-05-15 |
| ELV | EVP & Chief Financial Officer | 63,725 | $385.73 | $24.58M | $0 | 1 | 2023-03-03 |
| Elevance Health, Inc. (ANTM) Delisted | EVP & Chief Financial Officer | 46,857 | $482.58 | $22.61M | -$24.09M | 9 | 2022-03-03 |
| ANTX | EVP & Chief Financial Officer | 40,510 | $4.70 | $190.4K | -$5.65M | 6 | 2018-03-07 |
| Elevance Health, Inc. (WLP) Delisted | SVP & Chief Accounting Officer | 22,490 | — | — | -$6.56M | 13 | 2014-03-05 |
Recent Filings · Page 3 of 4
37 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-03-07 | ANTX | Tax (F) | −977 | -$162.2K | EDGAR |
| 2017-03-03 | ANTX | Mixed | +4,573 | -$49.0K | EDGAR |
| 2016-06-03 | ANTX | Grant (A) | +1,887 | $0 | EDGAR |
| 2015-03-04 | Elevance Health, Inc. (ANTM) Delisted | Mixed | −2,091 | -$3.87M | EDGAR |
| 2014-03-05 | Elevance Health, Inc. (WLP) Delisted | Mixed | +8,060 | -$290.3K | EDGAR |
| 2013-08-07 | Elevance Health, Inc. (WLP) Delisted | Mixed | — | -$1.09M | EDGAR |
| 2013-06-05 | Elevance Health, Inc. (WLP) Delisted | Tax (F) | −194 | -$15.0K | EDGAR |
| 2013-03-05 | Elevance Health, Inc. (WLP) Delisted | Grant (A) | +7,218 | $0 | EDGAR |
| 2012-12-12 | Elevance Health, Inc. (WLP) Delisted | Mixed | −23,939 | -$1.69M | EDGAR |
| 2012-12-06 | Elevance Health, Inc. (WLP) Delisted | Grant (A) | +1,757 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.